胃肠道疾病大鼠粪便微生物群变化及多组分药物调节的系统研究
Systematic Survey of the Alteration of the Faecal Microbiota in Rats With Gastrointestinal Disorder and Modulation by Multicomponent Drugs.
作者信息
Wu Yue, Wu Yang, Wu Hongwei, Wu Changxun, Ji Enhui, Xu Jing, Zhang Yi, Wei Junying, Zhao Yi, Yang Hongjun
机构信息
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
Medical Experimental Center of Chinese Academy of Traditional Chinese Medicine, Beijing, China.
出版信息
Front Pharmacol. 2021 Nov 2;12:670335. doi: 10.3389/fphar.2021.670335. eCollection 2021.
Gastrointestinal disorder (GID) is a global health disease which leads to heavy public medical burden. Disorders in the intestinal flora have been found in gastrointestinal disorder patients. However, the interaction between GID and the intestinal flora in faecal has not been studied comprehensively. In addition, multicomponent drugs represented by traditional Chinese medicine (TCM) are widely used for treating GID, but their modulation of the intestinal flora has not been investigated. Therefore, in this study, a high-throughput sequencing strategy was used to investigate alterations in the intestinal flora in a rat GID model, followed by an investigation of the modulation by a representative TCM, Xiaoerfupi (XEFP) granule. The results showed that in rats with GID, the relative abundances of Erysipelotrichaceae, Lachnospiraceae, Streptococcaceae increased and that of Ruminococcaceae decreased. At the macro level, the levels of LysoPC(16:0), LysoPC(20:2), LysoPC(15:0), LysoPC(20:2 (11Z, 14Z)), LysoPC(20:1), LysoPC(15:0), LysoPC(20:0) and LysoPE (0:0/20:0) in serum increased and levels of PC(36:4), PC(38:4), PC(o-36;4), PE (MonoMe(13,5)/MonoMe(11,5)) decreased. The imbalance of metabolites was restored by XEFP through pathway. Increase in the phyla Firmicutes/Bacteroidetes (F/B) ratio of the GID rats was restored by XEFP as well. Moreover, XEFP can relief the symptoms of GID rats by increasing bacteria Ruminococcaceae and decreasing Streptococcaceae Erysipelotrichaceae and Lachnospiraceae in faecal microbiota level. This study represents a comprehensive survey of the interaction between GID and the intestinal flora and a systematic evaluation of modulation by a multicomponent drug.
胃肠道疾病(GID)是一种全球性健康疾病,会导致沉重的公共医疗负担。在胃肠道疾病患者中已发现肠道菌群紊乱。然而,GID与粪便中肠道菌群之间的相互作用尚未得到全面研究。此外,以中药(TCM)为代表的多组分药物被广泛用于治疗GID,但其对肠道菌群的调节作用尚未得到研究。因此,在本研究中,采用高通量测序策略研究大鼠GID模型中肠道菌群的变化,随后研究代表性中药小儿扶脾(XEFP)颗粒的调节作用。结果表明,在患有GID的大鼠中,丹毒丝菌科、毛螺菌科、链球菌科的相对丰度增加,而瘤胃球菌科的相对丰度降低。在宏观层面上,血清中溶血磷脂酰胆碱(LysoPC)(16:0)、LysoPC(20:2)、LysoPC(15:0)、LysoPC(20:2(11Z,14Z))、LysoPC(20:1)、LysoPC(15:0)、LysoPC(20:0)和溶血磷脂酰乙醇胺(LysoPE)(0:0/20:0)的水平升高,而磷脂酰胆碱(PC)(36:4)、PC(38:4)、PC(o-36;4)、磷脂酰乙醇胺(PE)(单甲基(13,5)/单甲基(11,5))的水平降低。XEFP通过 途径恢复了代谢物的失衡。XEFP还恢复了GID大鼠厚壁菌门/拟杆菌门(F/B)比例的增加。此外,XEFP可以通过增加粪便微生物群水平中的瘤胃球菌科细菌和减少丹毒丝菌科、毛螺菌科和链球菌科来缓解GID大鼠的症状。本研究全面调查了GID与肠道菌群之间的相互作用,并对多组分药物的调节作用进行了系统评价。